ClinicalTrials.Veeva

Menu

The Efficiency of Robotic Hand Exoskeleton System in Stroke Patients

M

Marmara University

Status

Completed

Conditions

Stroke

Treatments

Other: Conventional physiotherapy
Other: Robotic Hand Exoskeleton System

Study type

Interventional

Funder types

Other

Identifiers

NCT05958628
MarmaraU-FTR-FO-01

Details and patient eligibility

About

The aim of our study is to investigate the effects of the robotic hand exoskeleton, on the spasticity, motor control skills, level of daily living activity, quality of life and functional independence of stroke patients.

Full description

Stroke is a condition that occurs as a result of an ischemic or hemorrhagic intracranial vascular event, is the third leading cause of death in the world and can lead to disability. Depending on the localization of brain damage after stroke, it is possible to talk about different prognoses and therefore different functional losses in the lower extremities, upper extremities and hand and wrist.

Today, various neurophysiological approaches, exercise strategies, electrotherapy modalities and assistive devices are used in the rehabilitation program suitable for the patient after stroke. In addition to these, robot-assisted therapy is gaining a place as an innovative approach in stroke rehabilitation with the developments in technology. Robot-assisted therapy is thought to both facilitate and intensify treatment after stroke and increase motor development.

The normal functions of the hand, which has many abilities and a complex structure, is extremely important to lead a free and active life. When the literature is examined, the success rate in the recovery of skills and functional recovery of the hand in stroke rehabilitation is low compared to the lower extremity and shoulder joint. More interventions are needed to increase the functional recovery of the hand. Studies should be conducted on robot-assisted treatment methods that allow active and passive exercises in the hand after stroke and contribute to neuroplasticity with an intensified and standardized program.

Our aim in this study is to investigate the efficacy of the Robotic Hand Exoskeleton System developed at Marmara University in order to reduce the physiotherapy process and increase the responses of patients who have partially lost their hand functions due to stroke and need rehabilitation in stroke patients.

Enrollment

36 patients

Sex

All

Ages

35 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being diagnosed with stroke by a neurologist
  • At least 3 months have passed after the stroke
  • Mini Mental State Examination score of at least 24
  • To be able to maintain sitting balance during working with the robot,
  • Having full range of motion in the metacarpophalangeal (MCP), proximal interphalangeal (PIF) and distal interphalangeal (DIF) joints,
  • Spasticity in finger flexor and extensor muscles ≤ 3 according to the Modified Ashworth Scale (MAS)
  • Being between the ages of 35-85

Exclusion criteria

  • Other neurological or orthopedic problems that may affect upper extremity function,
  • Cardiovascular vulnerability (severe uncontrolled hypertension, severe coronary artery disease, unstable angina)
  • Behavioral and cognitive conditions that affect treatment and make compliance difficult
  • Having botulinum toxin procedure in the last 6 months
  • Cardiac pacemakers
  • Those with skin ulcers
  • Pregnancy
  • History of metastatic cancer

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

36 participants in 2 patient groups

Control group
Other group
Description:
Participants in this group will receive a conventional physiotherapy program 3 times a week for 5 weeks, each session lasting 1 hour.
Treatment:
Other: Conventional physiotherapy
Intervention group
Experimental group
Description:
Participants in this group will receive Robotic Hand Exoskeleton System for 10 minutes in addition to 50 minutes of conventional physiotherapy 3 times a week for 5 weeks.
Treatment:
Other: Robotic Hand Exoskeleton System
Other: Conventional physiotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Fatma Öztürk, Msc; Özge Keniş Coşkun, assoc.prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems